Preventing and Managing Infections in Neutropenic Stem Cell Transplantation Recipients: Evidence-Based Review

The number of hematopoietic stem cell transplantations (HSCTs) performed annually is increasing. Although general survival rates have risen since 1990, mortality and morbidity from preventable complications can be improved. As a result, this article will review developments in preventing and managing infections in neutropenic HSCT recipients.